InnovAge Q4 Earnings Call Highlights
InnovAge reported Q4 cost of care rose 16.1% to $312.1M. It held $97.9M in cash, $43.4M in short-term investments, and $63.3M in debt. The company projected fiscal 2027 revenue of $1.05B-$1.085B, adjusted EBITDA of $105M-$115M, and 5%-7.5% growth. It outlined 'InnovAge 3.0' strategy, focusing on scaling and acquisitions.
How this was made
The 30-second read
Why it matters
The company sees rising operating costs and modest revenue growth, signaling a cautious outlook for investors in the senior‑care sector.
Market read
Earnings and guidance provide fresh data for traders evaluating senior‑care stocks and related healthcare ETFs.
What to watch
Potential policy changes in PACE reimbursement and state rate‑setting could materially affect results.
Background
InnovAge Holdings released its Q4 earnings call highlights, detailing cost increases and FY2027 guidance for revenue and EBITDA.
Ticker impact
InnovAge posted Q4 cost of care up 16.1% to $312.1 million and guided FY2027 revenue of $1.05‑$1.085 billion.
Potential modest upside if guidance beats expectations; downside risk if costs erode margins.
Guidance is in line with prior outlook but cost inflation could pressure earnings.
Market effects
Indicates pressure on senior‑care PACE providers as labor and pharmacy costs rise.
California and Colorado markets may see volatility due to pending PACE rate decisions.
Limited, primarily affects US senior‑care sector investors.
Counterpoint
Higher cost growth may outweigh modest revenue upside, leading to a price decline.
Key entities
- companyInnovAge Holdings, Inc.
US‑listed senior‑care provider (NASDAQ:INNV) reporting Q4 results and FY2027 guidance.
